The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Alcon Inc.’s ALC growth is driven by its robust Surgical business. The performance of the Vision Care arm also appears encouraging. However, concerns remain about the macroeconomic headwinds ...

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through ...

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

announces the closing of its acquisition of Infinity Laboratories, Inc. ("Infinity"). Founded in 1991, Infinity operates eight state-of-the-art laboratories across the United States and employs ...

Alcon Inc. (NYSE: ALC) has a higher price-to-earnings ratio of 43.70x compared to its average ratio. ALC has 36-month beta value of 0.98. Analysts have mixed views on the stock, with 7 analysts rating ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...